Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05944120 · ClinicalTrials.gov registry record · Phase 3
Decreasing On-Shift Stress With a Crisis Intervention Cart
A Phase 3 study of Decreasing On-Shift Stress With a Crisis Intervention Cart, sponsored by Methodist Health System.
- Completed
- Registry status
- Phase 3
- Development phase
- 443
- Enrollment target
- 1
- Study location
NCT05944120: Completed Phase 3 study of Decreasing On-Shift Stress With a Crisis Intervention Cart, sponsored by Methodist Health System.
NCT05944120 is a Phase 3 study of Decreasing On-Shift Stress With a Crisis Intervention Cart that has completed, run by Methodist Health System. The registered enrollment target is 443 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05944120, a Phase 3 study of Decreasing On-Shift Stress With a Crisis Intervention Cart, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 443 participants
- Enrollment target
- 1
- Study location
Study Summary
This Intervention study anticipates that 100 nurses, patient care technicians and unit secretaries in the acute care setting at four Methodist Health System facilities will provide surveys to participants who had interventions
Primary Outcome
The Effect of Crisis Intervention Cart filled with evidence-based stress-reducing interventions on reducing stress experienced during a shift using surveys. A 10-point Likert scale will be used with 1 being the lowest and 10 being the highest on the scale with 10 having highest level of self-perceived stress.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Aromatherapy patches
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 443 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2025-06-30 |
| Phase | Phase 3 |
What the finished NCT05944120 record still lists
NCT05944120 is an interventional study that assigns participants to a tested intervention. The registered 443 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Decreasing On-Shift Stress With a Crisis Intervention Cart appearing as the primary indexed condition, and to 1 intervention - of which Aromatherapy patches is the first listed.
NCT05944120 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05944120 about?
NCT05944120 is a clinical study titled "Decreasing On-Shift Stress With a Crisis Intervention Cart". This Intervention study anticipates that 100 nurses, patient care technicians and unit secretaries in the acute care setting at four Methodist Health System facilities will provide surveys to participants who had interventions
What is the current status of trial NCT05944120?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 443 participants. The study started on 2023-03-06. Estimated completion is 2025-06-30.
What conditions does trial NCT05944120 study?
This clinical trial studies the following conditions: Decreasing On-Shift Stress With a Crisis Intervention Cart.
What interventions are being tested in trial NCT05944120?
The interventions under investigation include: Aromatherapy patches (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05944120?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05944120 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05944120's enrollment target sits among peer trials
443 866th of 2000 higher than 1,134 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06780670 · 443 participants · Phase 2
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
- NCT06700343 · 444 participants · Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI